Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_assertion description "[In inflammatory bowel disease, increased production of prostaglandins by cyclooxygenase-2 (COX-2) contributes to bowel dysfunction, inflammatory edema, and hyperemia suggesting that inhibitors of COX-2 may have beneficial effect in gut inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_assertion evidence source_evidence_curated NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_assertion SIO_000772 11820457 NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_assertion wasDerivedFrom ctd_human-20150221 NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_assertion wasGeneratedBy ECO_0000218 NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.
- ctd_human-20150221 importedOn "2015-02-21" NP27719.RAiudk2mXfSLIPdCVBgC8vjOoIrwOFz-SQ2TGIpC3Bmr4130_provenance.